Related Experiment Video

Updated: Apr 14, 2026

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice
06:32

Protective Efficacy and Pulmonary Immune Response Following Subcutaneous and Intranasal BCG Administration in Mice

Published on: September 19, 2016

11.2K

Investigating the non-specific effects of BCG vaccination on the innate immune system in Ugandan neonates: study

Sarah Prentice1,2,3, Emily L Webb4, Hazel M Dockrell5,6,7

  • 1Wellcome Trust - Bloomsbury Centre for Global Health Research, London School of Hygiene and Tropical Medicine, Keppel Street, London, WC1E 7HT, UK. Sarah.prentice@lshtm.ac.uk.

Trials
|April 16, 2015
PubMed

Insights

Bacillus Calmette-Guérin (BCG) vaccination may protect infants against non-mycobacterial diseases. This study investigates BCG's impact on the innate immune system in Ugandan neonates to confirm these broad protective effects.

Area of Science:

  • Neonatal immunology
  • Infectious disease prevention
  • Vaccinology

Background:

  • Previous studies suggest Bacillus Calmette-Guérin (BCG) vaccination may offer protection against non-mycobacterial diseases in infants.
  • Further trials are needed in healthy term infants and non-West African settings to confirm these findings.
  • The biological mechanisms behind BCG's heterologous effects in neonates require elucidation.

Purpose of the Study:

  • To evaluate if BCG vaccination non-specifically enhances the innate immune system in term Ugandan neonates.
  • To assess if this enhancement leads to increased protection against various infectious diseases.
  • To investigate the optimal timing for BCG vaccination to maximize these protective effects.

Main Methods:

  • An investigator-blinded, randomized controlled trial involving 560 Ugandan neonates.
  • Comparison of infants receiving BCG at birth versus those receiving it at 6 weeks of age.
  • Primary outcomes focus on innate immune parameters; secondary outcomes include clinical illness measures.

Main Results:

  • This section is not available in the provided abstract.

Conclusions:

  • Investigating the broadly protective effects and optimal timing of neonatal BCG immunisation has significant public health implications.
  • Evidence of protection against heterologous pathogens supports timely BCG administration for all infants.
  • Findings could inform strategies for novel anti-tuberculosis vaccines and advocate for continued BCG use.
Abstract

More Related Videos

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux08:10

A Functional Whole Blood Assay to Measure Viability of Mycobacteria, using Reporter-Gene Tagged BCG or M.Tb BCG lux/M.Tb lux

Published on: September 14, 2011

14.3K
A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis08:46

A Neonatal Imaging Model of Gram-Negative Bacterial Sepsis

Published on: August 12, 2020

7.1K

Related Concept Videos

Development of Immunocompetence01:22

Development of Immunocompetence

The initiation of cell-mediated immunity can be observed as early as the third month of fetal growth, with active antibody-mediated immunity following approximately one month later.
The initial cells that migrate from the fetal thymus settle within the skin and epithelial tissues lining the mouth, digestive tract, and in females, the uterus and vagina. These cells, including skin-based dendritic cells, serve as antigen-presenting cells, playing a key role in T cell activation.
Subsequent T...
1.2K
Defense Against Bacterial Pathogens01:31

Defense Against Bacterial Pathogens

The human immune system is a complex network of cells, tissues, and organs that work together to defend the body against bacterial infections. It consists of various immune cells, each playing a specific role in the defense mechanism.
Phagocytes
Phagocytes are the frontline soldiers of the immune system. They include neutrophils and macrophages. Neutrophils are the most abundant type of white blood cell and are quickly mobilized to the site of infection. Macrophages are larger cells that patrol...
3.6K
Vaccinations01:51

Vaccinations

Overview
54.6K
Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from...
49
Regulation of Bacterial Virulence01:28

Regulation of Bacterial Virulence

Pathogenic bacteria employ a range of regulatory mechanisms to modulate the expression of virulence genes in response to environmental and host-derived signals. These mechanisms ensure that virulence factors are expressed only under favorable conditions, thereby optimizing infection and survival strategies.Mechanisms of Virulence RegulationKey regulatory strategies include:Two-Component Systems: These consist of a membrane-bound sensor kinase and a cytoplasmic response regulator. Environmental...
51
Immunodeficiency Diseases01:25

Immunodeficiency Diseases

Immunodeficiency disorders are conditions in which the immune system's ability to fight infectious disease and cancer is compromised or entirely absent. The immune system comprises a complex network of cells, tissues, and organs that work together to protect the body from potentially harmful invaders. When this system is deficient or not functioning properly, it leaves the body susceptible to infections, diseases, or other complications.
There are three main causes of immunodeficiency...
3.4K